STRATA CRITICAL MEDICAL INC (SRTA) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:SRTA • US0926671043

4.55 USD
-0.13 (-2.78%)
At close: Feb 10, 2026
4.55 USD
0 (0%)
After Hours: 2/10/2026, 8:00:00 PM

SRTA Key Statistics, Chart & Performance

Key Statistics
Market Cap392.98M
Revenue(TTM)228.76M
Net Income(TTM)40.39M
Shares86.37M
Float67.73M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.27
PEN/A
Fwd PEN/A
Earnings (Next)03-11
IPO2019-09-17
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
SRTA short term performance overview.The bars show the price performance of SRTA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

SRTA long term performance overview.The bars show the price performance of SRTA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of SRTA is 4.55 USD. In the past month the price decreased by -21.42%.

STRATA CRITICAL MEDICAL INC / SRTA Daily stock chart

SRTA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to SRTA.


Chartmill TA Rating
Chartmill Setup Rating

SRTA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SRTA. SRTA has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SRTA Financial Highlights

Over the last trailing twelve months SRTA reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS increased by 60.87% compared to the year before.


Industry RankSector Rank
PM (TTM) 17.65%
ROA 12.05%
ROE 14.27%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-66.67%
Sales Q2Q%-34.16%
EPS 1Y (TTM)60.87%
Revenue 1Y (TTM)-5.4%

SRTA Forecast & Estimates

8 analysts have analysed SRTA and the average price target is 9.82 USD. This implies a price increase of 115.77% is expected in the next year compared to the current price of 4.55.

For the next year, analysts expect an EPS growth of 58.65% and a revenue growth -12.66% for SRTA


Analysts
Analysts85
Price Target9.82 (115.82%)
EPS Next Y58.65%
Revenue Next Year-12.66%

SRTA Ownership

Ownership
Inst Owners60.26%
Ins Owners12.32%
Short Float %8.9%
Short Ratio6.86

SRTA Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.4596.185B
CI THE CIGNA GROUP9.2178.643B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2796.1324.001B
LH LABCORP HOLDINGS INC15.822.715B
DGX QUEST DIAGNOSTICS INC19.5321.275B
GH GUARDANT HEALTH INC N/A13.572B
DVA DAVITA INC10.539.717B
BTSG BRIGHTSPRING HEALTH SERVICES28.717.171B
CHE CHEMED CORP17.616.346B
RDNT RADNET INC88.075.335B

About SRTA

Company Profile

SRTA logo image Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the U.S. healthcare industry. The company is headquartered in New York City, New York and currently employs 310 full-time employees. The company went IPO on 2019-09-17. The firm focuses on the contractual and macro-non-correlated marketplaces for organ logistics and other medical services. Its subsidiary, Trinity Medical Solutions (Trinity), is engaged in the air and ground transportation of human organs for transplant, leveraging its asset-light platform to deliver logistics solutions to its customers across the United States. Trinity provides Organ Placement Services (TOPS) and Logistics Solutions for Transplant Centers and organ procurement organizations (OPOS). The firm also offers a full-service organ transplant service provider offering surgical recovery, NRP services, air and ground logistics and organ placement services.

Company Info

STRATA CRITICAL MEDICAL INC

31 Hudson Yards, 14Th Floor

New York City NEW YORK US

Employees: 310

SRTA Company Website

SRTA Investor Relations

Phone: 13026365400

STRATA CRITICAL MEDICAL INC / SRTA FAQ

What does STRATA CRITICAL MEDICAL INC do?

Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the U.S. healthcare industry. The company is headquartered in New York City, New York and currently employs 310 full-time employees. The company went IPO on 2019-09-17. The firm focuses on the contractual and macro-non-correlated marketplaces for organ logistics and other medical services. Its subsidiary, Trinity Medical Solutions (Trinity), is engaged in the air and ground transportation of human organs for transplant, leveraging its asset-light platform to deliver logistics solutions to its customers across the United States. Trinity provides Organ Placement Services (TOPS) and Logistics Solutions for Transplant Centers and organ procurement organizations (OPOS). The firm also offers a full-service organ transplant service provider offering surgical recovery, NRP services, air and ground logistics and organ placement services.


Can you provide the latest stock price for STRATA CRITICAL MEDICAL INC?

The current stock price of SRTA is 4.55 USD. The price decreased by -2.78% in the last trading session.


Does SRTA stock pay dividends?

SRTA does not pay a dividend.


What is the ChartMill rating of STRATA CRITICAL MEDICAL INC stock?

SRTA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Where is STRATA CRITICAL MEDICAL INC (SRTA) stock traded?

SRTA stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for STRATA CRITICAL MEDICAL INC?

STRATA CRITICAL MEDICAL INC (SRTA) operates in the Health Care sector and the Health Care Providers & Services industry.


How is the valuation of STRATA CRITICAL MEDICAL INC (SRTA) based on its PE ratio?

STRATA CRITICAL MEDICAL INC (SRTA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).